MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/1878-0261.70225

Медицинская библиотека · Molecular oncology · 2026

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Dienstmann Rodrigo, García-Galea Eduardo, O'Farrell Alice, Kinsella Zak, Meylan Maxime, Petitprez Florent, Arijs Ingrid, Venken Tom, Ps Hari, Lärkeryd Adrian, Miller Ian, Selves Janick, Meindl-Beinker Nadja, Ruiz-Pace Fiorella, Élez Elena, Comas-Navarro Raquel, Lincoln Frank, Fey Dirk, Nyamundanda Gift, Nolan Aoife, Lewin Joern, Perez-Lopez Raquel, Briody Jonathan, Bennett Kathleen, Kolch Walter, Matallanas David, Kel Alexander, Arenas Enrique, Arribas Joaquín, Ghesquière Bart, Tabernero Josep, Meilleroux Julie, McNamara Deborah, McDermott Ray, Lim Marvin, O'Reilly Mary, Bird Brian, Stack Lisa, Moloney Lucia, Morris Patrick, Egan Keith, Milewski Maciej, Scheuer Lars, Behringer Joachim, Bolz Georg, Salazar Ramon, Santos Cristina, Ruiz Andrea, Casey Orla, Murphy Verena, Ebert Matthias, Trusolino Livio, Lambrechts Diether, Sadanandam Anguraj, Sautès-Fridman Catherine, Prehn Jochen, Nuciforo Paolo, Fieschi Jacques, Monville Florence, O'Connor Darran, Fridman Wolf, Byrne Annette

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

To explore the immune microenvironment of RAS-mutated (RASmt) microsatellite stable (MSS) colon cancer (CC), we retrospectively performed whole exome sequencing, RNA sequencing, and robust digital pathology analyses and studied immune markers in a cohort of 161 patients treated with standard-of-care therapies with early stage disease (both fresh frozen and formalin-fixed paraffin-embedded [FFPE] samples) or 121 patients with metastatic setting (primary tumor FFPE samples). Only a small proportion of cases exhibited a highly infiltrated immune microenvironment, with a strong association between Immunoscore® (IS)-high (13% of the samples) and Tumor Lymphocytes Infiltrating Score (TuLIS)-high scores (25% of the samples). Immunoscore Immune-Checkpoint (ISIC)-high tumors (52% of the samples) shared a similar microenvironment composition to IS-high and TuLIS-like high tumors and displayed higher mutational burdens than ISIC-low tumors. In conclusion, a substantial proportion of MSS RASmt CCs exhibit high ISIC scores, meriting evaluation in prospective trials of immunotherapy-based combination regimens.

Для цитирования: Dienstmann Rodrigo, García-Galea Eduardo, O'Farrell Alice, Kinsella Zak, Meylan Maxime, Petitprez Florent, Arijs Ingrid, Venken Tom, Ps Hari, Lärkeryd Adrian, Miller Ian, Selves Janick, Meindl-Beinker Nadja, Ruiz-Pace Fiorella, Élez Elena, Comas-Navarro Raquel, Lincoln Frank, Fey Dirk, Nyamundanda Gift, Nolan Aoife, Lewin Joern, Perez-Lopez Raquel, Briody Jonathan, Bennett Kathleen, Kolch Walter, Matallanas David, Kel Alexander, Arenas Enrique, Arribas Joaquín, Ghesquière Bart, Tabernero Josep, Meilleroux Julie, McNamara Deborah, McDermott Ray, Lim Marvin, O'Reilly Mary, Bird Brian, Stack Lisa, Moloney Lucia, Morris Patrick, Egan Keith, Milewski Maciej, Scheuer Lars, Behringer Joachim, Bolz Georg, Salazar Ramon, Santos Cristina, Ruiz Andrea, Casey Orla, Murphy Verena, Ebert Matthias, Trusolino Livio, Lambrechts Diether, Sadanandam Anguraj, Sautès-Fridman Catherine, Prehn Jochen, Nuciforo Paolo, Fieschi Jacques, Monville Florence, O'Connor Darran, Fridman Wolf, Byrne Annette. Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.. Molecular oncology. 2026. DOI: 10.1002/1878-0261.70225.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.